Anebulo Pharmaceuticals, Inc. cotiza a 0.32 USD y tiene una capitalización bursátil de $13M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of…
| Periodo | 2025-11 | 2025-09 | 2025-09 | 2025-05 |
|---|---|---|---|---|
| Real | $-0.05 | $-0.05 | — | $-0.04 |
| Estimado | $-0.12 | $-0.05 | $-0.05 | $-0.05 |
| Sorpresa | +58.3% | +0.0% | — | +20.0% |
| Métrica | ANEB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -72.8% | -40.4% | -32.4% |
| ROA | -69.9% | -32.0% | -37.9% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |